| View |
|
DR-XY38898
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Ciltamin 750
|
750mg
|
Powder For Injection (Im/Iv)
|
Antibacterial (Penicillin)
|
Samjin Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
05 August 2023
|
28 December 2028
|
| View |
|
DR-XY38902
|
Tacrolimus
|
Rocimus
|
0.03% w/w
|
Topical Ointment
|
-
|
The Madras Pharmaceuticals
|
India
|
-
|
11 March 2022
|
03 January 2026
|
| View |
|
DR-XY38907
|
Ofloxacin
|
Dizoflox
|
3 mg/mL (0.3%)
|
Ophthalmic Solution (Eye Drops)
|
-
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
26 February 2021
|
06 January 2026
|
| View |
|
DR-XY38908
|
Atorvastatin (As Calcium)
|
Avator
|
40 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
15 December 2020
|
29 December 2025
|
| View |
|
DR-XY38909
|
Natalbes
|
Multivitamins + Minerals
|
Formulation: Each Capsule contains Retinol Palmitate (Vitamin A)-3000IU Ergocalciferol (Vitamin D2)-400IU Thiamine Nitrate (Vitamin B1)-2mg Riboflavin (Vitamin B2)-3mg Nicotinamide (Vitamin B3)-20mg Calcium Pantothenate (Vitamin B3)-3.45mg Pyridoxine Hydrochloride (Vitamin B6)-2.2mcg Cyanocobalamin (Vitamin B12)-3mcg Ascorbic Acid (equivalent to 113 mg Sodium Ascorbate)-100mg
Calcium Carbonate-375mg Iron (equivalent to 314 mg Ferrous Fumarate)-100mg Magnesium (as Sulfate)-34.5mg Folic Acid-1mg Zinc (as Sulfate)-1.38mg Copper (as Sulfate)-1.26mg Sodium Fluoride-2.21mg Manganese (as Sulfate)-1.54 lodine (equivalent to 197 mcg Potassium lodide)-150mcg
|
Softgel Capsule
|
-
|
Catalent Australia Pty. Ltd.
|
Australia
|
-
|
19 May 2021
|
28 December 2025
|
| View |
|
DR-XY38914
|
Metformin Hydrochloride
|
Glucotin
|
1 G
|
Film-Coated Tablet
|
-
|
LLOYD LABORATORIES, INC.
|
Philippines
|
-
|
26 November 2020
|
04 January 2026
|
| View |
|
DR-XY38922
|
Metoprolol Tartrate
|
Metoprim
|
100 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
09 January 2020
|
04 January 2025
|
| View |
|
DR-XY38925
|
Xylometazoline Hydrochloride
|
None
|
1 mg/mL (0.1%)
|
Nasal Spray Solution
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
04 December 2020
|
10 January 2026
|
| View |
|
DR-XY38929
|
Atenolol
|
None
|
100 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
12 October 2020
|
05 January 2026
|
| View |
|
DR-XY38932
|
Propofol
|
Nirfol
|
10mg/mL (1% w/v)
|
Emulsion for Injection (I.V.)
|
-
|
Aculife Healthcare Private Limited
|
India
|
-
|
29 December 2020
|
07 January 2026
|
| View |
|
DR-XY38934
|
Lacidipine
|
Lacibloc
|
6 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
12 October 2020
|
11 January 2026
|
| View |
|
DR-XY38936
|
Metronidazole
|
Nirmet
|
5 mg/mL (500 mg/100 mL)
|
Solution for Intravenous
Infusion
|
Antiprotozoal
|
Aculife Healthcare Private Limited
|
India
|
Automatic Renewal (Reconstruction)
|
12 August 2024
|
07 January 2026
|
| View |
DR-XY38938_PI_01.pdf
|
DR-XY38938
|
Montelukast (As Sodium)
|
Bronast
|
5 mg
|
Chewable Tablet
|
-
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
26 March 2021
|
11 January 2026
|
| View |
|
DR-XY38945
|
Motirex
|
Loperamide Hydrochloride
|
2mg
|
Capsule
|
-
|
New Myrex Laboratories, Inc.
|
Philippines
|
-
|
17 May 2021
|
13 January 2025
|
| View |
|
DR-XY38947
|
Linezolid
|
Zyvox
|
100mg/5mL
|
Powder For Oral Suspension
|
-
|
Pharmacia and Upjohn Company LLC
|
USA
|
Initial (Variation)
|
09 June 2023
|
09 June 2028
|
| View |
|
DR-XY38952
|
Paracetamol + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
|
Fluzep
|
325mg/20mg/2mg
|
Tablet
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
11 December 2020
|
13 January 2026
|
| View |
|
DR-XY38953
|
Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
|
Flukid
|
10mg/1mg per 5 mL
|
Syrup
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
18 December 2020
|
13 January 2026
|
| View |
|
DR-XY38957
|
Voriconazole
|
Vfend
|
200 mg
|
Lyophilized Powder for I.V. Infusion
|
Antimycotic (Triazole derivatives)
|
Pharmacia and Upjohn Company LLC
|
U.S.A.
|
Renewal
|
08 January 2024
|
19 December 2028
|
| View |
|
DR-XY38958
|
Cefdinir
|
Omnicef [for Export Only]
|
125mg/ 5mL
|
Powder for Oral Suspension
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
29 October 2022
|
18 January 2026
|
| View |
|
DR-XY38958 (FOR EXPORT ONLY)
|
Cefdinir
|
Omnicef
|
125mg/5mL
|
Powder for Oral Suspension
|
-
|
Interphil Laboratories, Inc
|
Philippines
|
Renewal
|
29 October 2022
|
18 January 2026
|